INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)
Track This Opportunity
Create an account to track opportunities.
About This Opportunity
This opportunity provides phased grant funding (R61/R33) from the National Institutes of Health (NIH) for clinical trials focused on Down syndrome research. It's designed for researchers and institutions conducting rigorous clinical studies to advance understanding and treatment related to Down syndrome, offering substantial non-dilutive capital.
Eligibility Requirements
Application Guide
Selection is based on scientific merit, relevance to Down syndrome research, rigor of the clinical trial design, and qualifications of the research team. Alignment with NIH's INCLUDE Project goals is crucial.
Develop a strong scientific premise and a meticulously designed clinical trial protocol. Clearly articulate the potential impact on Down syndrome research and patient care, and ensure your proposal aligns with the specific objectives of the INCLUDE Project.
Geographic Coverage
Links & Resources
Source & freshness
Last verified: 6/16/2026
Primary source: Official source page
Refresh cadence: Listings are refreshed weekly.
Reminder: Confirm eligibility and deadlines before applying.